Similar articles

• Antihypertensive pharmacotherapy in a developing economy: pattern, acquisition costs and conformity to international guidelines in a tertiary-care setting.

  Amira CO, Okubadejo NU. Amira CO, et al. J Hum Hypertens. 2006 Nov;20(11):894-7. doi: 10.1038/sj.jhh.1002080. Epub 2006 Aug 10. J Hum Hypertens. 2006. PMID: 16915299 No abstract available.
• [German Hypertension League update. What does the ALLHAT Study really mean?].

  [No authors listed] [No authors listed] MMW Fortschr Med. 2003 Jun 5;145(23):45-6. MMW Fortschr Med. 2003. PMID: 12854226 German. No abstract available.
• Following evidence-based prescribing guidelines for antihypertensives could save big bucks.

  Rollins G. Rollins G. Rep Med Guidel Outcomes Res. 2004 Jun 11;15(11):1, 6-7. Rep Med Guidel Outcomes Res. 2004. PMID: 15241883 No abstract available.
• [Fully possible to reduce the costs of hypertension treatment].

  Wettermark B, Angman A, Hjemdahl P. Wettermark B, et al. Lakartidningen. 2009 Jun 3-9;106(23):1558-62. Lakartidningen. 2009. PMID: 19583013 Review. Swedish. No abstract available.
• Trends in the market for antihypertensive drugs.

  Ali MA, Rizvi S, Syed BA. Ali MA, et al. Nat Rev Drug Discov. 2017 May;16(5):309-310. doi: 10.1038/nrd.2016.262. Epub 2017 Mar 10. Nat Rev Drug Discov. 2017. PMID: 28280260 Review. No abstract available.